NewsBot
10-16-2009, 03:30 PM
Questcor Pharmaceuticals, Inc. announced that it has resubmitted its filing to the U.S. Food & Drug Administration for its supplemental New Drug Application seeking approval to market H.P. Acthar Gel for the treatment of infantile spasms.
More... (http://www.topix.net/med/neurology/2009/10/questcor-resubmits-supplemental-new-drug-application-to-fda-for-h-p?fromrss=1)
(From Topix Neurology)
More... (http://www.topix.net/med/neurology/2009/10/questcor-resubmits-supplemental-new-drug-application-to-fda-for-h-p?fromrss=1)
(From Topix Neurology)